ProfileGDS4132 / 51226_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 29% 32% 35% 33% 28% 27% 32% 31% 33% 31% 30% 32% 34% 31% 30% 28% 28% 35% 31% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10169.703829
GSM201543Muscle PCOS pioglitazone 12171.267132
GSM201544Muscle PCOS pioglitazone 16189.691835
GSM201545Muscle PCOS pioglitazone 20189.565533
GSM201829Muscle PCOS pioglitazone 23171.790528
GSM201830Muscle PCOS pioglitazon 25168.012327
GSM201831Muscle PCOS pioglitazone 27176.446832
GSM201832Muscle PCOS pioglitazone 3177.024731
GSM201833Muscle PCOS pioglitazone 4178.013833
GSM201834Muscle PCOS pioglitazone 8174.322631
GSM201835Muscle PCOS after pioglitazone 10259.297630
GSM201836Muscle PCOS after pioglitazone 12267.730932
GSM201837Muscle PCOS after pioglitazone 16271.113434
GSM201838Muscle PCOS after pioglitazone 20267.4831
GSM201839Muscle PCOS after pioglitazone 23267.043730
GSM201840Muscle PCOS after pioglitazone 25263.769228
GSM201841Muscle PCOS after pioglitazone 27254.563428
GSM201842Muscle PCOS after pioglitazone 3271.489635
GSM201843Muscle PCOS after pioglitazone 4275.452631
GSM201844Muscle PCOS after pioglitazone 8267.71130